CTLA4 and metastatic neoplasm: The authors have used a clinically relevant pre-clinical model of metastatic tumor and have shown that the combination therapy of NDV and CTLA-4 checkpoint blockade controlled both local and distant tumors better than either anti-CTLA-4 or NDV treatment alone.